| Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease P Chatterjee, S Pedrini, E Stoops, K Goozee, VL Villemagne, PR Asih, ... Translational psychiatry 11 (1), 27, 2021 | 326 | 2021 |
| Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease P Chatterjee, S Pedrini, NJ Ashton, M Tegg, K Goozee, AK Singh, ... Alzheimer's & Dementia 18 (6), 1141-1154, 2022 | 149 | 2022 |
| Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ... Journal of Alzheimer's Disease 62 (3), 965-992, 2018 | 138 | 2018 |
| Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease SM Golzan, K Goozee, D Georgevsky, A Avolio, P Chatterjee, K Shen, ... Alzheimer's research & therapy 9, 1-9, 2017 | 123 | 2017 |
| Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross‐sectional and longitudinal study in the AIBL cohort P Chatterjee, S Pedrini, JD Doecke, R Thota, VL Villemagne, V Doré, ... Alzheimer's & Dementia 19 (4), 1117-1134, 2023 | 116 | 2023 |
| Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease K Huynh, WLF Lim, C Giles, KS Jayawardana, A Salim, NA Mellett, ... Nature communications 11 (1), 5698, 2020 | 106 | 2020 |
| Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau KR Jacobs, CK Lim, K Blennow, H Zetterberg, P Chatterjee, RN Martins, ... Neurobiology of aging 80, 11-20, 2019 | 106 | 2019 |
| Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer’s disease P Chatterjee, M Fernando, B Fernando, CB Dias, T Shah, R Silva, ... Mechanisms of Ageing and Development 186, 111209, 2020 | 105 | 2020 |
| A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease NJ Ashton, AJ Nevado-Holgado, IS Barber, S Lynham, V Gupta, ... Science advances 5 (2), eaau7220, 2019 | 76 | 2019 |
| Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load K Goozee, P Chatterjee, I James, K Shen, HR Sohrabi, PR Asih, P Dave, ... Molecular psychiatry 23 (8), 1807-1812, 2018 | 71 | 2018 |
| Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease TM Shah, SM Gupta, P Chatterjee, M Campbell, RN Martins Molecular psychiatry 22 (3), 353-363, 2017 | 70 | 2017 |
| Association of plasma neurofilament light chain with neocortical amyloid-β load and cognitive performance in cognitively normal elderly participants P Chatterjee, K Goozee, HR Sohrabi, K Shen, T Shah, PR Asih, P Dave, ... Journal of Alzheimer's Disease 63 (2), 479-487, 2018 | 67 | 2018 |
| Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease P Chatterjee, H Zetterberg, K Goozee, CK Lim, KR Jacobs, NJ Ashton, ... Journal of neuroinflammation 16, 1-12, 2019 | 58 | 2019 |
| Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease G Cadby, C Giles, PE Melton, K Huynh, NA Mellett, T Duong, A Nguyen, ... Nature communications 13 (1), 3124, 2022 | 57 | 2022 |
| Ultrasensitive detection of plasma amyloid-β as a biomarker for cognitively normal elderly individuals at risk of Alzheimer’s disease P Chatterjee, M Elmi, K Goozee, T Shah, HR Sohrabi, CB Dias, S Pedrini, ... Journal of Alzheimer's Disease 71 (3), 775-783, 2019 | 57 | 2019 |
| Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study P Chatterjee, K Goozee, CK Lim, I James, K Shen, KR Jacobs, ... Scientific Reports 8 (1), 8008, 2018 | 55 | 2018 |
| Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease K Goozee, P Chatterjee, I James, K Shen, HR Sohrabi, PR Asih, P Dave, ... Scientific reports 7 (1), 676, 2017 | 55 | 2017 |
| Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of … MJ Sharman, E Gyengesi, H Liang, P Chatterjee, T Karl, QX Li, MR Wenk, ... Neurobiology of disease 124, 505-519, 2019 | 53 | 2019 |
| Plasma phospholipid and sphingolipid alterations in presenilin1 mutation carriers: A pilot study P Chatterjee, WLF Lim, G Shui, VB Gupta, I James, AM Fagan, C Xiong, ... Journal of Alzheimer's disease 50 (3), 887-894, 2016 | 53 | 2016 |
| Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer’s disease J Muenchhoff, A Poljak, A Thalamuthu, VB Gupta, P Chatterjee, M Raftery, ... Scientific reports 6 (1), 29078, 2016 | 42 | 2016 |
